BiotechTube

Vadadustat + Darbepoetin alfa

Phase 3Completed
0 watching 0 views this week📈 Rising
69
Hype Score

Development Stage

✓
Pre-clinical
✓
Phase 1
✓
Phase 2
4
Phase 3
5
Approved
Indication / Disease

Anemia

Conditions

Anemia, Non-Dialysis-Dependent Chronic Kidney Disease

Trial Timeline

Dec 1, 2015 → Jul 31, 2020

NCT ID
NCT02648347

About Vadadustat + Darbepoetin alfa

Vadadustat + Darbepoetin alfa is a phase 3 stage product being developed by Akebia Therapeutics for Anemia. The current trial status is completed. This product is registered under clinical trial identifier NCT02648347. Target conditions include Anemia, Non-Dialysis-Dependent Chronic Kidney Disease.

Hype Score Breakdown

Clinical
27
Activity
18
Company
2
Novelty
9
Community
10

Clinical Trials (6)

NCT IDPhaseStatus
NCT04313153Phase 3Completed
NCT03242967Phase 3Withdrawn
NCT02892149Phase 3Completed
NCT02865850Phase 3Completed
NCT02680574Phase 3Completed
NCT02648347Phase 3Completed

Competing Products

20 competing products in Anemia

See all competitors
ProductCompanyStageHype Score
Aranesp®AmgenApproved
84
KER-047Keros TherapeuticsPhase 2
44
LY2787106Eli LillyPhase 1
33
R744 + R744Chugai PharmaceuticalPhase 3
77
epoetin beta + placeboChugai PharmaceuticalPhase 3
77
recombinant human erythropoietin + recombinant human erythropoietin placeboChugai PharmaceuticalPhase 3
77
recombinant human erythropoietin + recombinant human erythropoietinChugai PharmaceuticalPhase 3
77
darbepoetin alfaAmgenPhase 3
76
PrasugrelDaiichi SankyoPhase 1
33
Prasugrel + PlaceboDaiichi SankyoPhase 2
52
roxadustatAstellas PharmaPhase 3
77
roxadustatAstellas PharmaPhase 3
77
Roxadustat + Darbepoetin alfaAstellas PharmaPhase 3
77
AlefaceptAstellas PharmaPhase 1
33
RoxadustatAstellas PharmaPhase 2
52
roxadustatAstellas PharmaPhase 1
33
Roxadustat + PlaceboAstellas PharmaPhase 3
77
RoxadustatAstellas PharmaPre-clinical
23
Roxadustat + Epoetin AlfaAstellas PharmaPhase 3
77
roxadustat + Darbepoetin alfaAstellas PharmaPhase 3
77

Other Products from Akebia Therapeutics

Ferric Citrate 1 gram Oral Tablet + Standard of care phosphate-lowering therapyApproved
77
Vadadustat + Darbepoetin alfaPhase 3
69
VadadustatPhase 3
69
Vadadustat + Darbepoetin alfaPhase 3
69
Ferric Citrate 1 GM Oral Tablet [AURYXIA] + PlaceboPhase 3
69